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Silicone is a liquid polymer previously considered to be immunologically inert and favored in cosmetic
procedures. Increasing evidence shows a multisystemic inﬂammatory reaction to its administration
constituting the silicone embolism syndrome (SES). The majority of adverse effects are seen in the
pulmonary system resulting in extensive diffuse alveolar damage and ultimately ARDS. Neurologic
involvement occurs frequently and is uniformly fatal. Large volume injections, high pressure inﬁltrations
and prior exposure to silicone have been implicated, with an IgG polydimethylsiloxane antibody
described. Most patients meet Schonﬁeld criteria for fat embolism syndrome and treatment is largely
supportive. As the illicit use of injectable silicone rises worldwide, so does the incidence of related
morbidities and fatalities, necessitating a high index of suspicion for SES in patients with neurologic or
pulmonary symptoms and recent exposure to liquid silicone. We report an unusual case of multi-organ
dysfunction following silicone injection.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Case report
A previously healthy 20-year-old female from England had
ﬂown into the US with friends for a “pumping party”. She arrived
with the intention of injecting 3000 ccs of hospital grade silicone
into her thighs and buttocks, with lesser quantities for her friends
who had previously received silicone injections without compli-
cations. Approximately 4 h after administration of the injections
she began to experience chest tightness withmild dyspnea andwas
taken to the ER.
On physical examination, the patient was in no distress while
breathing room air. Vital signs were normal. The lungs, heart, and
abdominal examinations revealed no abnormalities. The extremi-
ties demonstrated extensive bilateral greater trochanteric swelling
without erythema with a palpable doughy consistency. Neurologic
examination revealed no focal deﬁcits.
Laboratory data including complete blood count, serum chem-
istry, cardiac enzymes and urine for toxicology screening were all
negative. Initial electrocardiogram was normal and chest radio-
graphs showed diffuse interstitial inﬁltrates and minimal pulmo-
nary vascular congestion (Fig. 1).
Ninety minutes later, she became lethargic, markedly dyspneic
and diaphoretic. Arterial blood gas analysis on 100% oxygen werensoye).
-NC-ND license.pH 7.29, pCO2 37 mmHg, pO2 53 mmHg, and oxygen saturation
82%. She was intubated and transferred to the ICU. Chest CT
revealed subcentimeter non-calciﬁed pulmonary nodules, periph-
eral ground-glass opacities and interlobular septal thickening in all
lung lobes (Fig. 2).
What is the diagnosis?
2. Discussion
Silicone embolism syndrome (SES) is a potentially fatal, multi-
systemic complication that results from the illegal cosmetic injec-
tion of liquid silicone (polydimethylsiloxane). Although silicone
polymers were favored for use in cosmetic procedures (Fig. 3) as
they were previously believed to be immunologically inert
compounds with high thermal stability and minimal tissue reac-
tion,1 there is increasing evidence showing a widespread inﬂam-
matory reaction to its administration.2
Beyond the occurrence of direct intravascular injection which
frequently occurs in illicit cosmetic silicone administration, embolic
phenomena can also occur as a result of silicone penetration into
the microvasculature in the setting of increased perivascular tissue
pressure. The majority of adverse effects are seen in the pulmonary
system with a spectrum of events ranging from acute silicone
pneumonitis (usually characterized by fever, respiratory insufﬁ-
ciency and bilateral interstitial inﬁltrates on chest radiographs) to
silicone-induced embolic phenomena. These are associated with
vascular congestion and hypersensitivity pneumonitis resulting in
Fig. 1. Initial chest radiograph showing diffuse interstitial inﬁltrates and minimal
pulmonary vascular congestion.
Fig. 3. A Pelvic CT coronal slice depicting areas of silicone injection into the gluteal and
trochanteric areas bilaterally.
A.O. Adegunsoye et al. / Respiratory Medicine Case Reports 5 (2012) 34e36 35extensive diffuse alveolar damage and ultimately ARDS.3 Most
patients develop clinical signs within the ﬁrst 24 h of silicone
administration and the onset of symptoms has been linked to
a higher mortality rate (20%).4 The most frequent symptoms
include hypoxemia, dyspnea, fever, chest pain, cough and hemop-
tysis.1 Bronchoalveolar lavage (BAL) commonly reveals alveolar
hemorrhage, and a restrictive pattern is usually observed on
pulmonary function studies. While the acute presentation is typical
for the majority of patients, delayed-onset pneumonitis and
injection-site inﬂammation occurring years after silicone admin-
istration has been described. Migration of micro-droplets of sili-
cone could also assume a delayed presentation in the form of
pulmonary ﬁbrosis.4 Occasionally, pulmonary toxicity has been
described to lag behind CNS manifestations especially when initial
chest radiography and pulmonary examinations are benign in the
presence of lethargy. Increasing release of silicone emboli from the
source results in a slow progression to ARDS similar to the mani-
festation of heroin induced pulmonary edema.5 Neurologic
sequelae of silicone embolism vary frommild alteration in levels of
consciousness to frank coma. Interestingly, the absence of under-
lying cardiac septal defects does not preclude the occurrence of
neurologic manifestations, as microinfarcts in white matter
following cerebral silicone embolism has been described in theseFig. 2. Chest CT showing subcentimeter pulmonary nodules, peripheral ground-glass
opacities and interlobular septal thickening in all lung lobes.individuals and observed to be uniformly fatal.2 Large volume
injections, high pressure inﬁltrations and prior exposure to silicone
have been associatedwith aworse prognosis and increased rapidity
of symptom onset.2 The presence of an IgG polydimethylsiloxane
antibody which selectively binds to the silicone polymers has been
implicated in this inﬂammatory process. Histology typically reveals
multi-organ involvement with granulomas diffusely dispersed
within the cardiopulmonary, renal, hepatic and gastrointestinal
organ systems. Histopathologic analysis with the aid of infrared
spectrophotometry and atomic absorption reveals these granu-
lomas to consist of silicone vacuoles, tissue macrophages, neutro-
phils, eosinophils and ﬁbrin deposits. Pulmonary silicone embolism
characteristically results in a consistent chest CT imaging pattern of
bilateral peripheral ground-glass opacities and interlobular septal
thickening as portrayed by the present patient.4
The mechanism of silicone injury to pulmonary capillaries
closely mimics fat embolism with the occurrence of bilateral alve-
olar hemorrhages and diffuse presence of silicone droplets in
pulmonary alveolar macrophages and lung capillaries. Similar to fat
embolism syndrome (FES) in which inappropriate activation of the
coagulation cascade has been demonstrated in experimental and
bone marrow models, spontaneous thrombosis of the internal
jugular vein has been described in pulmonary silicone embolism.
Ingestion of silicone and fat by these alveolar macrophages has also
been postulated to result in modulation of pulmonary immuno-
regulatory mechanisms and provoke an exaggerated inﬂammatory
response. These suggest a common pathophysiologic mechanism
involving the coagulation system in both FES and SES. Notably,
most patients with SES meet Schonﬁeld criteria for fat embolism
syndrome where the presence of petechial hemorrhages, chest x-
ray changes, hypoxemia, tachycardia, tachypnea, confusion and
fever are used to determine a cumulative score.1
While treatment is largely supportive with supplemental
oxygen and high dose steroid administration constituting the
mainstay of therapy, the use of adjunct salvage mechanical venti-
lation techniques, and recruitment maneuvers like prone ventila-
tion have been suggested to improve oxygenation.2
The present patient appeared to be in ARDS from pulmonary
silicone embolism and presented issues of futility of care exacer-
bated by unprecedented high doses of silicone injection. These
facilitated a progressively rapid decline in her clinical course. She
rapidly deteriorated despite application of evidence based proto-
cols for treatment of ARDS, and lapsed into pulseless electrical
activity, expiring 3 h post intubation. Illicit use of injectable silicone
is on the rise in the United States and abroad. With this comes an
increasing incidence of related morbidities and fatalities. A high
A.O. Adegunsoye et al. / Respiratory Medicine Case Reports 5 (2012) 34e3636index of suspicion for SES should be triggered in patients with
neurologic or pulmonary symptoms and recent exposure to liquid
silicone.
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